Physician profile
Patrick B Murphy
NPI 1467930867
$31,952.81
in general payments reported to CMS, 2019-2025
12 companies · $3,765 in 2025
The $3,765 reported for 2025 was more than what 84% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,273 · 2021: $7,732 · 2022: $1,228 · 2023: $14K · 2024: $3,877 · 2025: $3,765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Consulting Fee: $6,000 · Food and Beverage: $1,462 · Travel and Lodging: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,450.00 |
| Consulting Fee | $6,000.00 |
| Food and Beverage | $1,461.94 |
| Travel and Lodging | $808.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20,879.81 | 2021-2025 | Spyglass Discover, Axios, Spyglass |
| Intuitive Surgical, INC. | $8,876.63 | 2021-2024 | Da Vinci Surgical System |
| Prytime Medical Devices, INC. | $1,135.00 | 2019 | |
| W. L. Gore & Associates, INC. | $296.56 | 2024-2025 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Baxter Healthcare | $149.75 | 2024 | Perclot, Tisseel |
| Medtronic, INC. | $145.53 | 2024 | Ligasure |
| Portola Pharmaceuticals, LLC | $133.18 | 2019 | |
| Grifols USA, LLC | $120.43 | 2024 | Thrombate III |
| Aroa Biosurgery Incorporated | $113.49 | 2025 | |
| Zimmer Biomet Holdings, INC. | $97.86 | 2024 | Advantagerib |
| Zoll Circulation INC | $4.57 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.